To the full analysis
Buyback calculator for Collegium Pharmaceutical
Collegium Pharmaceutical stock: key metrics
COLLCollegium Pharmaceutical had an operating margin of 24% and a return on invested capital (ROIC) of 14.4% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2013 | no data | no data | no data |
| 2014 | no data | no data | no data |
| 2015 | no data | no data | no data |
| 2016 | 87.6% | −5,498.7% | −5,504.1% |
| 2017 | 90.9% | −264.9% | −262.9% |
| 2018 | 40.9% | −7.4% | −14.0% |
| 2019 | 34.7% | −8.0% | −7.7% |
| 2020 | 58.0% | 18.1% | 8.6% |
| 2021 | 54.4% | 6.4% | 25.8% |
| 2022 | 45.2% | 7.2% | −5.4% |
| 2023 | 57.5% | 29.5% | 8.5% |
| 2024 | 59.8% | 26.9% | 11.0% |
| 2025 | 59.3% | 24.0% | 8.1% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2013 | −100.0% | no data | −100.0% |
| 2014 | 146.4% | no data | −100.0% |
| 2015 | −32.0% | −44.5% | −27.9% |
| 2016 | −69.8% | −62.9% | −58.1% |
| 2017 | −71.9% | −48.2% | −55.2% |
| 2018 | −42.7% | −15.5% | −13.4% |
| 2019 | −26.0% | −17.6% | −7.4% |
| 2020 | 14.4% | 50.2% | 4.2% |
| 2021 | 35.2% | 5.0% | 10.3% |
| 2022 | −12.8% | 5.2% | −2.1% |
| 2023 | 24.6% | 16.5% | 4.2% |
| 2024 | 30.2% | 16.1% | 4.2% |
| 2025 | 20.8% | 14.4% | 3.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.